These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10903474)
21. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives. O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430 [TBL] [Abstract][Full Text] [Related]
22. Cholesterol absorption inhibitors in development as potential therapeutics. Kajinami K; Takekoshi N Expert Opin Investig Drugs; 2002 Jun; 11(6):831-5. PubMed ID: 12036426 [TBL] [Abstract][Full Text] [Related]
23. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. Wang Y; Yi X; Ghanam K; Zhang S; Zhao T; Zhu X Metabolism; 2014 Sep; 63(9):1167-77. PubMed ID: 25002181 [TBL] [Abstract][Full Text] [Related]
24. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739 [TBL] [Abstract][Full Text] [Related]
25. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties. Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption. Ichihashi T; Izawa M; Miyata K; Mizui T; Hirano K; Takagishi Y J Pharmacol Exp Ther; 1998 Jan; 284(1):43-50. PubMed ID: 9435159 [TBL] [Abstract][Full Text] [Related]
28. Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters. Wang X; Guan L; Zhao Y; Lei L; Liu Y; Ma KY; Wang L; Man SW; Wang J; Huang Y; Chen ZY Atherosclerosis; 2015 Sep; 242(1):77-86. PubMed ID: 26184696 [TBL] [Abstract][Full Text] [Related]
35. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor. Kitayama K; Koga T; Inaba T; Fujioka T Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766 [TBL] [Abstract][Full Text] [Related]
36. Possible hypocholesterolemic action of 15-ketosterol: replacement of dietary cholesterol absorption. Chu AJ Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):115-23. PubMed ID: 3244810 [TBL] [Abstract][Full Text] [Related]
37. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption. Kvaernø L; Werder M; Hauser H; Carreira EM J Med Chem; 2005 Sep; 48(19):6035-53. PubMed ID: 16162006 [TBL] [Abstract][Full Text] [Related]